Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients.
about
Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individualsUtilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependenceA pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disordersEffect of incarceration history on outcomes of primary care office-based buprenorphine/naloxoneCosts of care for persons with opioid dependence in commercial integrated health systems.Cost-effectiveness of computer-assisted training in cognitive-behavioral therapy as an adjunct to standard care for addiction.Cost evaluation of evidence-based treatmentsSupply of buprenorphine waivered physicians: the influence of state policies.The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation.Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care.Physicians' attitudes towards office-based delivery of methadone maintenance therapy: results from a cross-sectional survey of Nova Scotia primary-care physicians.Treatment of prescription opioid disorders in Canada: looking at the 'other epidemic'?The cost of providing methadone maintenance treatment in Ontario, Canada.Economic analysis of a multi-site prevention program: assessment of program costs and characterizing site-level variabilityNarrative review: buprenorphine for opioid-dependent patients in office practice.Lack of clinically significant drug interactions between nevirapine and buprenorphine.Application of multivariate probabilistic (Bayesian) networks to substance use disorder risk stratification and cost estimation.Cost-effectiveness of subdermal implantable buprenorphine versus sublingual buprenorphine to treat opioid use disorder.Economic Evaluations of Opioid Use Disorder Interventions.Breaking the addictive cycle of the system: improving US criminal justice practices to address substance use disorders."This is not who I want to be:" experiences of opioid-dependent youth before, and during, combined buprenorphine and behavioral treatment.Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization.Factors associated with buprenorphine versus methadone use in pregnancy.Effects of injectable extended-release naltrexone (XR-NTX) for opioid dependence on residential rehabilitation outcomes and early follow-up.Buprenorphine versus methadone use in opiate detoxification, are there other factors that should be considered?Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome.Feasibility of double-blind clinical trials with oral diacetylmorphine: a randomized controlled phase II study in an inpatient setting.Office-Based Buprenorphine Versus Clinic-Based Methadone: A Cost-Effectiveness Analysis.
P2860
Q26745747-2CE883F2-8965-48F3-A8FE-EF70C70AAECDQ26865674-A01CEF07-DF9F-443F-9199-9E18B69EB0B0Q27000732-00E85406-1BC6-473A-B4C8-7ECBD55DDFEBQ33898696-30DFFE7B-5942-45AC-B312-81C32BD9042FQ34079752-BA45E056-427A-4DFB-8820-A3CEB6529158Q34551982-2B89CF86-6A4F-435B-847A-FE3753315E96Q35059940-A6050569-8714-4A07-9000-54ADA8B5EE6BQ35571613-8A0CBE19-E146-4B4D-85B5-1C6A894AA80FQ35726267-EF31C52D-C46A-4B73-A3FC-815F65F7C2C4Q35980664-3E2AFE1F-7D5B-4D15-B6F3-BD9F3D7B4949Q36241476-C59241E2-AC52-4277-A94F-FB162753FF04Q36662425-37C9A43D-DB8F-4118-ADC4-10982FAEE839Q36766215-160AA7F2-7365-49C0-9D73-95C083A4486AQ36800266-42739134-5AF6-4FC1-8C4E-1CF47A344C8AQ36959052-8BE72FD8-00F4-42D0-82B2-A70F918E6DE8Q37045349-DEFC1D7A-4D72-4E5E-B172-6509B0C4195CQ37695070-57E66AA8-0E18-4391-AA9E-26ABA3E3AE09Q38730784-4DB7CD2F-D474-40CF-8528-E59BE74001EDQ38784603-6FE41813-C19D-4F87-AFF3-46040A35066BQ39031469-61A69CDC-228A-4A3E-ACD6-BC5A78D0F7A6Q39349178-C86175CE-0F5E-4138-ABDA-AF637FCCB88BQ40216408-788F185A-97C9-4BC2-9735-FD3AD14CEEEDQ40777859-0C4CEB86-7696-4D10-8BAD-3B46057F5160Q41474014-A7CAF0B6-F04C-452E-8AF0-3BE4899B362FQ43066207-04B0AA9B-96CA-4D45-9A39-715D8463D600Q47162080-19767BD4-69C4-4DA6-98E0-23A718E5A2EEQ52301249-CA52EC8C-5CE5-451A-88B5-9449C286B3BAQ53140893-DD8E3C03-F003-41A6-BAA5-54A23CAF18D1
P2860
Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cost analysis of clinic and of ...... in clinically stable patients.
@en
Cost analysis of clinic and of ...... in clinically stable patients.
@nl
type
label
Cost analysis of clinic and of ...... in clinically stable patients.
@en
Cost analysis of clinic and of ...... in clinically stable patients.
@nl
prefLabel
Cost analysis of clinic and of ...... in clinically stable patients.
@en
Cost analysis of clinic and of ...... in clinically stable patients.
@nl
P2093
P2860
P1476
Cost analysis of clinic and of ...... in clinically stable patients.
@en
P2093
Emlyn S Jones
Jody L Sindelar
Patrick G O'Connor
Richard S Schottenfeld
P2860
P304
P356
10.1016/J.DRUGALCDEP.2008.07.013
P577
2008-09-19T00:00:00Z